-
Something wrong with this record ?
Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time
L. Stepankova, E. Kralikova, K. Zvolska, A. Pankova, Z. Adamcekova, M. Kuhn, D. Noland
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 2003-03-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1993-01-01 to 1 year ago
PubMed
32592219
DOI
10.1111/add.15175
Knihovny.cz E-resources
- MeSH
- Ambulatory Care Facilities MeSH
- Cohort Studies MeSH
- Smoking epidemiology MeSH
- Smokers statistics & numerical data MeSH
- Smoking Cessation Agents therapeutic use MeSH
- Humans MeSH
- Smoking Cessation methods MeSH
- Tobacco Use Disorder therapy MeSH
- Tobacco Use Cessation Devices statistics & numerical data MeSH
- Recurrence MeSH
- Retrospective Studies MeSH
- Varenicline therapeutic use MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
AIMS: To compare success rates and characteristics of smokers treated a second time by a smokers' clinic with success rates of their first treatment. DESIGN: Retrospective cohort study. SETTING: Tobacco Dependence Treatment clinic in Prague, Czech Republic, between 2005 and 2017. PARTICIPANTS: A total of 5225 smokers treated either once (n = 5006, single treatment sample, SS) or also second time (n = 219, re-treated sample, RS), on average 4.47 years after the first visit. INTERVENTION: Smokers received intensive treatment of tobacco dependence with pharmacotherapy options. Outcomes were evaluated after 1 year. In case of failure or relapse, participants could undergo re-treatment in the same setting at least 1 year after the start of the first treatment. MEASUREMENTS: Twelve-month self-reported continuous abstinence; CO-validated (≤ 6 parts per million); number of visits; type of pharmacotherapy; mental health history; Fagerström Test for Cigarette Dependence; time between first and second treatment. RESULTS: The abstinence rate in the SS was 34.8% [95% confidence interval (CI) = 33.4%, 36.1%] and in the RS was 37% (95% CI = 30.6%, 43.8%) and 39.7% (95% CI = 33.2%, 45.5%) for their first and second treatments, respectively. The samples were comparable on smoking and socio-demographic characteristics and pharmacotherapy used, but the RS in the second treatment had a higher prevalence of diagnosed mental health disorder at 39.3% (95% CI = 32.8%; 46.1%) compared with 23.7% (95% CI = 22.5%; 24.9%) in the SS. Participants who initiated their second quit attempt 1 to 2 years after the first one were less successful than those who initiated their second quit attempt later (25 versus 43%; P < 0.05). The results of the first treatment cycle were not found to be a reliable predictor for outcomes of the second cycle of treatment in univariate or multivariate logistic regression (odds ratio = 1.35, 95% CI = 0.70-2.63, P = 0.373). CONCLUSION: In Prague, Czech Republic, smokers re-attending stop-smoking treatment more than 2 years after their previous quit attempt appear to achieve similar success rates to those being treated for the first time.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026093
- 003
- CZ-PrNML
- 005
- 20211026133219.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/add.15175 $2 doi
- 035 __
- $a (PubMed)32592219
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Stepankova, Lenka $u Centre for Tobacco Dependence, 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
- 245 10
- $a Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time / $c L. Stepankova, E. Kralikova, K. Zvolska, A. Pankova, Z. Adamcekova, M. Kuhn, D. Noland
- 520 9_
- $a AIMS: To compare success rates and characteristics of smokers treated a second time by a smokers' clinic with success rates of their first treatment. DESIGN: Retrospective cohort study. SETTING: Tobacco Dependence Treatment clinic in Prague, Czech Republic, between 2005 and 2017. PARTICIPANTS: A total of 5225 smokers treated either once (n = 5006, single treatment sample, SS) or also second time (n = 219, re-treated sample, RS), on average 4.47 years after the first visit. INTERVENTION: Smokers received intensive treatment of tobacco dependence with pharmacotherapy options. Outcomes were evaluated after 1 year. In case of failure or relapse, participants could undergo re-treatment in the same setting at least 1 year after the start of the first treatment. MEASUREMENTS: Twelve-month self-reported continuous abstinence; CO-validated (≤ 6 parts per million); number of visits; type of pharmacotherapy; mental health history; Fagerström Test for Cigarette Dependence; time between first and second treatment. RESULTS: The abstinence rate in the SS was 34.8% [95% confidence interval (CI) = 33.4%, 36.1%] and in the RS was 37% (95% CI = 30.6%, 43.8%) and 39.7% (95% CI = 33.2%, 45.5%) for their first and second treatments, respectively. The samples were comparable on smoking and socio-demographic characteristics and pharmacotherapy used, but the RS in the second treatment had a higher prevalence of diagnosed mental health disorder at 39.3% (95% CI = 32.8%; 46.1%) compared with 23.7% (95% CI = 22.5%; 24.9%) in the SS. Participants who initiated their second quit attempt 1 to 2 years after the first one were less successful than those who initiated their second quit attempt later (25 versus 43%; P < 0.05). The results of the first treatment cycle were not found to be a reliable predictor for outcomes of the second cycle of treatment in univariate or multivariate logistic regression (odds ratio = 1.35, 95% CI = 0.70-2.63, P = 0.373). CONCLUSION: In Prague, Czech Republic, smokers re-attending stop-smoking treatment more than 2 years after their previous quit attempt appear to achieve similar success rates to those being treated for the first time.
- 650 _2
- $a ambulantní zařízení $7 D000554
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a kuřáci $x statistika a číselné údaje $7 D000074285
- 650 _2
- $a kouření $x epidemiologie $7 D012907
- 650 _2
- $a odvykání kouření $x metody $7 D016540
- 650 _2
- $a látky pro odvykání kouření $x terapeutické užití $7 D000077444
- 650 _2
- $a prostředky pro ukončení závislosti na tabáku $x statistika a číselné údaje $7 D061485
- 650 _2
- $a poruchy vyvolané užíváním tabáku $x terapie $7 D014029
- 650 _2
- $a vareniklin $x terapeutické užití $7 D000068580
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kralikova, Eva $u Centre for Tobacco Dependence, 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $u Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Zvolska, Kamila $u Centre for Tobacco Dependence, 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Pankova, Alexandra $u Centre for Tobacco Dependence, 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $u Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Adamcekova, Zuzana $u Centre for Tobacco Dependence, 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Kuhn, Matyas $u Institute of Biostatistics and Analyses at the Faculty of Medicine and the Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Noland, Derek $u Behavioral Health and Wellness Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA
- 773 0_
- $w MED00000153 $t Addiction (Abingdon, England) $x 1360-0443 $g Roč. 116, č. 2 (2021), s. 346-355
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32592219 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133226 $b ABA008
- 999 __
- $a ok $b bmc $g 1714952 $s 1146600
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 116 $c 2 $d 346-355 $e 20200718 $i 1360-0443 $m Addiction $n Addiction $x MED00000153
- LZP __
- $a Pubmed-20211013